Tymlos 80 MCG dose pen injectr 1.56ML
Ended Awarded
- Contract number
- SPE2DB25FQ60M
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,011
Award facts
- Contract value 100% obligated
- $14,010.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a firm fixed-price delivery order valued at $14,010.78 for Tymlos 80 micrograms dose pen injectables (1.56 milliliters). The award, issued on April 23, 2025, with an ultimate completion date of April 24, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499.999 billion and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products supporting medical supply needs across military health facilities.
DMS Pharmaceutical Group leverages its status as a woman-owned small business to compete effectively in federal procurement markets while maintaining a robust portfolio of pharmaceutical product deliveries to the Department of Defense healthcare system. The SPE2DB contract vehicle allows the DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, biologics, medical consumables, and specialty medications. This particular delivery order for Tymlos, a treatment for osteoporosis, reflects the company's continued role as a critical supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription medications to military health facilities nationwide.
Quick answers
Who was awarded contract SPE2DB25FQ60M?
SPE2DB25FQ60M was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on April 23, 2025.
How much is contract SPE2DB25FQ60M worth?
The government has obligated $14,011 on SPE2DB25FQ60M.
Is contract SPE2DB25FQ60M an order under another contract?
Yes. SPE2DB25FQ60M is a delivery order under SPE2DB20D9226, an indefinite delivery contract.
Was contract SPE2DB25FQ60M competed?
The extent of competition for SPE2DB25FQ60M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award